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Abstract
This work reports the biological evaluation of nanosized hydroxyapatite (HAp) previously synthesized
by continuous-ﬂowprecipitation in a scaled-upmeso oscillatoryﬂow reactor (meso-OFR). Physico-
chemical characterization of the synthesizedHAp suggests high surface reactivity namely because of
its high speciﬁc surface area and low crystallinity. On the other hand, in vitro biomineralization assays
demonstrated the apatite-forming activity of the preparedHAp and their higher surface reactivity
when compared to a commercial HAp. Furthermore, human osteoblastic-like (Saos-2) cells culture
evidenced that the synthesizedHAp stimulated cell proliferation, especially when applied at lower
concentrations (30 and 50 μgml−1), although its cellular uptake behavior. Therefore, the prepared
HAp shows immense potential as biomedicalmaterial, as well as drug and gene delivery vehicle. The
results are also very promising regarding further scaling up of the process, as the designed
methodology allow for the preparation in a continuousmode of nanosizedHApwith controlled
physico-chemical properties.
Introduction
Calciumphosphates (CaPs) have been extensively used in biomedical applications, namely as substitute
materials in dentistry and orthopaedic surgery for the regeneration of damaged hard tissues [1–3].
Hydroxyapatite (HAp), Ca10(PO4)6(OH)2, is themost well-knownCaP since it shares similar chemical and
crystallographic properties with themain inorganic component of bone and teeth enamel [2, 4, 5]. These
attributes infer exceptional biocompatibility, bioactivity, and osteoconductivity [6], providingHAp the
capability to lead to bone formation/mineralization and formbondswith the surrounding bone and connective
tissues [7]. In this context, nanosizedHAphas stimulated great interest in bone tissue engineering. Indeed,
features ofHApnanoparticles are closer to features of biological HAp, since themineral part of human bone is
mainlymade of nanostructuredHAp crystals [2, 4, 8–12]. According to the literature, nanosizedHAphas
demonstrated to exhibit better biological properties when compared to that of coarser grainedHAp [4, 9–12],
promotingmore readily osteointegration and subsequent bone tissue formation. Studies have reported that
HApnanoparticles exhibit improved sinterability and enhanced densiﬁcation due to greater surface area [9, 10].
Further, nanosizedHAp is expected to have better bioactivity when compared tomicrosizedHAp [11, 12].
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However, several other applications ofHApnanoparticles are also in progress. For instance, nanosizedHAp
demonstrates great potential as delivery vehicle formolecules such as proteins, drugs andDNA [11, 13]. Besides
its established biocompatibility [13, 14], its high speciﬁc surface area and high surface reactivity promote an easy
binding of great amount ofmolecules through simple adsorption [15–17]. In addition, its small size precludes
immune system activation [13]. Due to its low solubility in physiological conditions, HAp provides a protective
environment that shieldsmolecules fromdegradation, while providing a pathway for controlled release
[13, 16, 18].More recently, surfacemodiﬁcation ofHApnanoparticles has been performed through their
conjugationwith functional groups to provide a cell- or tissue- speciﬁc drug delivery [13]. In this way,
concentration of drugs in the bloodstream isminimized and therefore systemic toxicity is reduced [16]. HAp
nanoparticles composites have been prepared aswell, to enhance and attribute additional properties, such as
antimicrobial properties through silver incorporation [19, 20] and enhance osteoblasts function (like
proliferation) by dopingwithmetal ions [18]. Other functional properties such as photoluminescence [14, 15]
andmagnetism [21, 22] can be attributed toHApnanoparticles through doping andmagnetitematerial
combining, enabling hence their use in bioimaging and cancer therapy, respectively.
NanosizedHApparticles can be prepared by a variety ofmethodologies includingwet chemical
precipitation, hydrothermal technique, sol-gel approach,microemulsion and solid-state reaction [12, 23, 24].
Among thesemethods, wet chemical precipitation is themost simplest route for the synthesis of nanozisedHAp
[24, 25]. Besides its low cost and easy application in industrial production [25], wet chemical precipitation has
the advantage of a precise control over themorphology and size of particles [12]. However, precipitation from
solution has the disadvantage of lacking control of the phase purity of nanoparticles [12, 26]. On the other hand,
traditional wetmechanochemical processes usually lead to post-processing aggregation problems. Therefore,
ﬁnding conditions for a controllable synthesis of nanosizedHApwith speciﬁc characteristics is a relevant
scientiﬁc and technological challenge [27].
Recently, we reported the preparation ofHApnanoparticles by continuous-ﬂowprecipitation in a scaled-up
meso oscillatoryﬂow reactor (OFR), under near-physiological conditions of pH and temperature [28]. The
synthesizedHApnanoparticles show improved characteristics when compared to theHApnanoparticles
produced in a stirred tank batch reactor and a commercial HAp, namely a narrow size distribution and amean
size (d50) of about 77 nm. The scaled-upmeso-OFRused is based on amesoscale (millilitre) device that was
redesigned to suit some of the bioprocess applications requirements. The sharp bafﬂeswere replaced by smooth
periodic constrictions (SPC), thus reducing the high shear regions thatmay be crucial to some cell cultures. The
straight tube and the smooth periodic constrictions were incorporated as a single piece, thusmaking it easy for
sterilisation. Additionally, themeso-OFRhas been proved to result into signiﬁcant enhancement in processes
such asmass transfer and particlemixing [29–31] due to its efﬁcientmixingmechanism (oscillatory ﬂow
mixing). The liquid ormultiphaseﬂuid is typically oscillated in the axial direction and thismotion interacts with
the constrictions forming vortices,mixing intensity being controlled by the oscillation frequency and amplitude.
In turn, traditional stirred tank batch reactors usually employed for the production of syntheticHAp often lead
to inconsistences in product speciﬁcations due to their lowmixing efﬁciency [32]. Furthermore, batchmode
operation provides only limited amounts ofmaterial and crystallization conditionsmay change duringmultiple
syntheses, while continuousmode operation allows amore efﬁcient use of reagents and enhanced
reproducibility of results because allmaterial crystallizes under uniform conditions [33].
In the present work, the biological evaluation of theHApnanoparticles prepared in the scaled-upmeso-OFR
is assessed as an alternative route for commercially solutions presently available in themarket for biomedical
purposes. A comparative studywas developed to evaluate the effect of theHApparticles on cell viability,
proliferation andmorphology (MTS,DNA and SEManalysis). In addition, simulated body ﬂuid (SBF) studies
up to 60 days were carried out in order to provide an indication of the in vitromineralization potential of the
synthesizedHApnanoparticles.
Experimental section
HApnanoparticles synthesis
HApnanoparticles were synthesized by continuous-ﬂowprecipitation in a scaled-upmeso-OFRwith an
approximate volume of 30 ml (ﬁgure 1). The nanoparticles were obtained bymixing a saturated calcium
hydroxide (Sigma-Aldrich, 95%) aqueous solution (0.019 26M) and an orthophosphoric acid (Sigma-Aldrich,
85%) aqueous solution (0.011 54M). The initialmixingmolar ratioCa/Pwas 1.33 and the residence time τwas
3.3 min. Themixing conditions, i.e., the frequency, f, and the amplitude, x0, were ﬁxed at 1.83 Hz and 4.5 mm,
respectively. Experiments were conducted under near-physiological conditions of temperature (37 °C) and
pH (6.65), which is particularly relevant when preparingHAp formedical purposes. It is important to underline
that theHApnanoparticles were used as-prepared, without thermal treatment andwithout granulometric
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separation. Further details on the experimental installation aswell as themethodology can be found inCastro
et al [28].
HApnanoparticles characterization
Suspensionswerewithdrawn at the outlet of themeso reactor, centrifuged (at 1500 rpm for 5 min), andwashed
twicewith ultrapurewater and pure ethanol (99.8%), which stops the solid−liquid reaction21. The precipitate
was then dried overnight at 60 °Candweighed for the estimation of themass of the crystals obtained, giving an
approximate yield of 1 mgml−1. The obtained powder and a commercial HAp (Calciumhydroxyapatite,
Spectrum,minimum40meshes, Ca5HO13P3)were characterized by x-ray diffraction (XRD; PanAlytical X’Pert
PROAlfa-1 diffractometer withλCuKα= 1.540 56 Å), Fourier transform infrared spectroscopy (FTIR;
BomemMB-154S), and scanning electronmicroscopy (SEM; FEIQuanta 400FEGESEM/EDAXGenesis X4M
with an accelerating voltage of 15 kV and 20 kV), where samples were covered by a 10 nm layer of gold. TheCa/P
molar ratio was calculated for both synthesized and commercial HAp, after dissolving the powders in 0.5 MHCl
solution and quantifying the amount of calcium (Ca) and phosphorus (P) present. Atomic absorption
spectroscopy (AA400, Perkin-Elmer, Norwalk, CT)was used to quantify the amount of Ca at 422.7 nm. To
eliminate the interference of phosphate in themeasurement of calcium, 0.1 ml of the sample solutionwas
diluted in 5 ml of 0.625% wt of LaCl3 that acts as a release agent. The P concentrationwas analyzed by the
‘molybdenumblue’method [34] using aUV-light spectrophotometer (ShimadzuUV1800), at 820 nm. For
bothmethods, 3 replicates were analyzed and the average values calculated.Multi point Brunauer–Emmett–
Teller (BET) surface areameasurements were also performed on aQuantachromeAutosorb AS-1 instrument at
−196 °C. Prior to the analysis the samples were outgassed in vacuumat 300 °C for 2 h. Regarding particle size
distribution, both synthesized and commercial HApwere analysed by laser diffraction (LS 230, Beckman
Coulter).
Figure 1. (A) Schematic representation of themeso oscillatoryﬂow reactor (meso-OFR) and (B) experimental installation for the
continuous-ﬂowprecipitation ofHAp (based onCastro et al [28]).
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In vitromineralization
According toKokubo andTakadama [35], the potential in vivo bioactivity of a biomaterialmay be inferred by its
ability to form apatite on its surfacewhilst immersed in simulated body ﬂuid (SBF). Although SBF does not
simulate accurately the physiological conditions [36] and somematerials have shownnot tomineralize in the
presence of SBF [37, 38], the presence of in vitromineralization is considered a strong indication of in vivo
mineralization ability. In this way, a SBF solutionwas prepared in laboratory according to theKokubomethod
[35]. Table 1 gives the ion concentration of SBF and its comparisonwith human blood plasma. Also, its pHwas
adjusted to 7.40 exactly at 36.5 °C. In vitro assays were then achieved by soaking 100 mg ofHAppowder into
100 ml of SBF solutionmaintained at 37 °Cand under agitation at 50 rpm.HApparticles were incubated for
various time periods (0, 1, 3, 7, 15, 30 and 60 days), without refreshing or adding SBF solution. After incubation
for a particular time period, the samples were centrifuged at 5000 rpm for 5 min, and after decanting the
supernatant, the particles were washedwith ultra-purewater, and thenwith ethanol to stop the reaction. The
dryingwas achieved in an oven at 60 °Cduring 24 h. Assayswere carried out in triplicate for both synthesized
and commercial HAp particles (Calciumhydroxyapatite, Spectrum,minimum40meshes, Ca5HO13P3),
assessed as a control condition. The SBF solution collected at each time point was characterized by Inductively
Coupled PlasmaOptical Emission Spectroscopy (ICP-OES—Horiba Jobin YvonActivaM) to evaluate the ionic
exchange betweenHApparticles and SBF liquid, and the physico-chemical properties of the powders were
studied by Fourier transform infrared spectroscopy (FTIR—BomemMB-154S), x-ray diffraction (XRD—
PanAlytical X’Pert PROAlfa-1 diffractometer withλCuKα= 1.540 56 Å) and Scanning ElectronMicroscopy
(SEM—FEIQuanta 400FEGESEM/EDAXGenesis X4Mwith an accelerating voltage of 20 kV).
In vitro cytotoxicity and cell behavior
• Seeding and exposure of Saos-2 cells toHApnanoparticles
A human osteoblastic osteosarcoma cell line (Saos-2), was used to assess the eventual cytotoxicity and cell
behavior in the presence of the producedHApnanoparticles. For that purpose, cells were grown asmonolayer
cultures in standard basalmedium consisting ofDulbecco’sModiﬁed Eagle’sMedium (DMEM; Sigma
Aldrich, Germany) supplementedwith 10% fetal bovine serum (FBS; BiochromAG,Germany) and 1%
antibiotic-antimycotic solution (Gibco, GB). At conﬂuence, cells were detached from the cultureﬂasks using
TrypLE Express enzymewith phenol red (Life Technologies, Carlsbad, CA), centrifuged, ressuspended in
culturemedium and seeded in 48-well cell culture plates (Falcon) at a density of 1× 104 cells cm−2. After 24 h
of attachment, cells were cultured under static conditions in basalmedium supplementedwith different
concentrations (30 μg ml−1; 50 μg ml−1; 100 μg ml−1 and 200 μg ml−1) ofHApparticles, prepared in the
meso-OFR and commercial HAp (Calciumhydroxyapatite, Spectrum,minimum40meshes, Ca5HO13P3),
assessed as control condition. Cells were cultured for 1, 3 and 7 days in the presence of the testedHAp
particles. Tissue culture polystyrene (TCPS; Sarstedt, USA) coverslips were used to assess cellmorphology
by SEM.
• MTS assay
A 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophynyl)-2H-tetrazolium) (MTS)
assaywas performed to evaluate the cytotoxicity of the synthesized and commercial HAp particles in
comparison to latex (positive control for cell death). After 1, 3 and 7 days of culture, the culturemediumwas
removed and replaced by 300 μl ofmixed solution containing serum-free culturemedium (without phenol
red) andMTS (CellTiter 96One SolutionCell ProliferationAssayKit, Promega, PA,USA). After incubation
for 3 h at 37 °C in an atmosphere with 5%CO2, the optical density (OD)wasmeasured at 490 nmusing a plate
Table 1.Nominal ion concentrations of SBF in
comparisonwith those in human blood plasma.
Ion concentrations (mM)
Ion Blood plasma Simulated ﬂuid
Na+ 142.0 142.0
K+ 5.0 5.0
Mg2+ 1.5 1.5
Ca2+ 2.5 2.5
Cl− 103.0 147.8
HCO3− 27.0 4.2
HPO43- 1.0 1.0
SO42- 0.5 0.5
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reader (MolecularDevices, CA,USA). Cell viability was calculated by subtracting themeanODvalue of the
blank (samples without cells) from the ones of the tested concentrations of synthesizedHAp and controls. The
MTS assaywas performed in triplicate.
• DNAassay
Saos-2 cell proliferationwas assessed by using a ﬂuorimetric double-strandDNAquantiﬁcation kit
(PicoGreen,Molecular Probes, InvitrogenCorporation, USA) followingmanufacturer’s instructions.
Samples previously frozen at−80 °Cwere thawed at room temperature and the supernatant ﬂuorescence
measured (485 nmexcitation and 528 nmemission) in amicroplate reader (SynergyHT, BioTek Instruments,
USA). DNA amountwas calculated according to a standard curve and by subtracting the ﬂuorescence
measurements of samples without cells. TheDNA assaywas performed in triplicate.
• Cellmorphology and distribution by SEM
After each pre-deﬁned culturing time, the cell-seeded TCPSswerewashedwith Phosphate Buffered Saline
(PBS; Sigma,USA) andﬁxedwith 2.5% glutaraldehyde (Sigma, USA) solution in PBS. After rising againwith
PBS, samples were dehydrated using a series of ethanol solutions (30%, 50%, 60%, 70%, 80%, 90%and 100%v/
v) and treatedwith hexamethylidisilazane (HMDS; ElectronMicroscopy Sciences, USA). Samples were sputter
coatedwith gold (Fisons Instruments, Sputter Coater SC502, UK) prior to analysis using a Leica Cambridge S360
Scanning ElectronMicroscope and themicrographs were taken at an accelerating voltage of 15 kV at different
magniﬁcations.
Results and discussion
Physico-chemical properties of synthesizedHAp
SynthetizedHApnanoparticles were previously characterised [28] in terms of their size (ﬁgure 2) and
morphology (ﬁgures 3(C) and (D)). Results show that the synthesizedHAphas a lowermean size (d50 of about
77 nm) than the commercial HAp (d50 of about 400 nm). They also evidence that the synthesizedHAp is
constituted by aggregated rod-like shaped nanoparticles (of about 100 nm long and 20 nmwidth), while the
commercial HAp is characterized by aggregated rod-like shapedmicrosized particles.
Table 2 presents the estimatedCa/Pmolar ratio aswell as the speciﬁc surface area (SSA) of both synthesized
and commercial HAp. Results evidence that bothHAppowders have aCa/Pmolar ratio higher than the
stoichiometric value (1, 67), suggesting thus carbonate substituted hydroxyapatite, characteristic similar to the
apatite phase present in natural bone [11, 27, 39]. Additionally, it is possible to verify that the synthesizedHAp
has a lower amount of calciumwhen compared to the commercial HAp. Results also indicate that the prepared
HAphas a higher speciﬁc surface area than the commercial HAp.
Concerning phase identiﬁcation and crystallinity, FTIR spectra (ﬁgure 4) andXRDpatterns (ﬁgure 5) of
both synthesized and commercial HAp (referred as synthesizedHAp 0 days and commercial HAp 0 days) suggest
that both powders are constituted by low crystalline calcium-deﬁcient carbonated hydroxyapatite. From ﬁgure 4
FTIR spectra exhibit apatite characteristic absorption bands [40], namely bands assigned to the phosphate group
PO43- at 962–1100 cm
−1 and the hydroxyl groupOH− at 3571 and 630 cm−1. Broadening of the PO43- bands
Figure 2.Particle size distribution in number of both synthesized and commercial HAp.
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indicates small size and low crystallinity of bothHAppowders [41, 42]. The peak assigned to the stretchingmode
υS (3571 cm−1) ofOH- is not evidenced in the spectrumof the synthesizedHAp,whichmay be due to an overlap
with the broad peak of the adsorbedwater around 3700–3000 cm−1. Presence of adsorbedwater is also
conﬁrmed by the existence of a peak at 1643 cm−1, assigned to the bendingmode υ2 ofHOH. In the case of the
preparedHAp, this could be related to the process itself, as experiments were performed at low temperature and
without a ripening (ageing) treatment [28]. Absorption bandswere also observed at 1455 and 1420 cm−1,
especially in the spectra of the commercial HAp. Those are due to the stretching and bendingmodes of C–Oand
P–Obonds and air carbonated CO32- ions. In addition, the peak around 875 cm
−1can be assigned to the
vibrational frequencies of carbonate (CO32 )- or hydrogen phosphate (HPO42 )- ions. As to the peak observed
around 2360 cm−1, it is associated to the atmospheric CO2. Figure 5 shows theXRDpatterns of both synthesized
and commercial HAp powders. The diffraction peaks were identiﬁed using a reference pattern forHAp (JCPDS
9-0432). All themajor peaks ofHAp are present in bothXRDpatterns alongwith a fewminor peaks
corresponding to carbonatedHAp.One can also remark that diffraction peaks aremarkedly broader in the case
of the synthesizedHAp,whichmay indicate smaller size and lower crystallinity when compared to the
commercial HAp. Besides, peaks assigned toKCl (namely at 28° 2θ and 40.5° 2θ)were observed in the
diffraction pattern of the producedHAp. Asmentioned in a previous work [28], thismay be due to the occlusion
Figure 3.Variation of elemental concentration of phosphorus (P) (A) and calcium (Ca) (B) in SBF as function of soaking time (the
error bars are standard deviations from three independent experiments). SEM images of both (C) synthesized and (D) commercial
HAp, at different times of immersion in SBF.
Table 2.Ca/Pmolar ratio and speciﬁc surface area (SSA) of
both synthesized and commercial HAp.
Ca/Pmolar ratio SSA (m2 g−1)
SynthesizedHAp 1.72 70, 8
Commercial HAp 1.87 53, 3
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of KCl present in themother liquor, which could have been trapped in the aggregated particles and crystallized at
the drying step.
In vitromineralization
Figure 3 shows the variation in calcium (Ca) and phosphorus (P) ion concentrations in the SBF solution as
function of the immersion time for both synthesized and commercial HAp particles. A signiﬁcant decline in
bothCa and P ion concentrations was observed from theﬁrst day of immersion. After 30 days of immersion the
Ca and P ion levels in the SBF solution became approximately constant for both powders studied. Further, the
overall depletion rate of Ca ion concentration from the SBF solutionwas higher for the preparedHAp than the
commercial HAp (ﬁgure 3(B)), while the decrease in P ion concentration from the SBFwasmore pronounced
for the commercial HAp (ﬁgure 3(A)). The decrease inCa and P concentrations in SBF solutionmay indicate
that these ionswere accumulated on the surface of theHApparticles. This accumulation due to the electrostatic
attraction increases the supersaturation near theHAp surface, leading, as a result, to the precipitation of a new
CaPphase [43]. As observed in these experiments, precipitation seems to start almost immediately after
Figure 4. FTIR spectra of both synthesized (A) and commercial (B)HAp, at different times of immersion in SBF.
Figure 5.XRDpatterns of both synthesized and commercial HAp, at different times of immersion in SBF.
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immersion, although the assessment of Ca andP ion concentrationwas only done after 1 day of immersion.
According toKim [44], precipitates can immediately formwhen theHAppowders are soaked in SBF. In fact, the
isoelectric point ofHAp inwater is at pH ranging between 5 and 7 [45], lower than the pHof the SBF (7.4).
Therefore, once immersed in SBFHAp exhibits negative surface charge by exposing hydroxyl and phosphate
groups [45]. This negative charge interacts with the positive Ca ions in the ﬂuid,making the surface acquire
positive charge, which in turn interacts with the negative phosphate ions. Regarding the consumption rate of Ca
ions, thismight be affected by themagnitude of the initial surface negativity ofHAp [44]. As described above, the
preparedHAphas a lower calcium content, suggesting thereby amore negative surface when compared to the
commercial HAp [46, 47].Moreover, the lower dimensions (ﬁgures 2 and 3) and the higher surface area (table 2)
of the synthesizedHApparticlesmake them to adsorbmore ions on their surface, leading to an increased degree
of supersaturation of the surrounding ﬂuidwith respect to apatite, and thus accelerating the precipitation
process [27, 39, 48]. The surface reactivity of the synthesizedHApmay also be attributed to the existence of
adsorbedwater on its surface [28], constituting an ion reservoir for the growth of a new apatite phase [49].
Concerning the phosphorus consumption rate, it follows the same trend as the calcium consumption rate for
both powders. This can be explained by the consumption of both calcium and phosphorus upon the deposition
of aCaP layer at the surface of both synthesized and commercial HAp particles.
Figures 3(C) and 2(D) represent SEM images of both synthesized and commercial HAp particles immersed
in SBF for 0, 15, 30 and 60 days. Figure 3(C) shows a regular distribution of aggregated rod-like nanoparticles
before and after soaking in SBF for the producedHAp. Regarding the commercial HAp (ﬁgure 3(D)), it ismainly
formed by highly aggregated rod-likemicroparticles, unless after 30 and 60 days of immersion in SBFwhere the
presence ofmicrosized plate-like particles is veriﬁed. Thismay indicate the formation of a newCaPphase or
phase transformation, althoughHAp can exhibit various sizes and shapes [12]. Regarding aggregation of the
particles, it is probably attributed to their high surface-area-to-volume ratio, which results in a high surface
tension that they tend to lower by adhering to one another [50]. Furthermore, SEM images evidence that the
synthesizedHApparticles are smaller and uniformly distributed in size when comparedwith the commercial
HAp. This was also conﬁrmed byHApparticles size distribution data for bothHApswithout soaking in SBF
(ﬁgure 2), where the synthesizedHAp exhibits a lowermean size and a narrower size distribution than the
commercial HAp. Indeed, the efﬁcient oscillatorymixingmechanismdeveloped in themeso-OFR leads to a
more homogeneous reactionmedium and therefore to amore homogeneous distribution of supersaturation,
promoting thusmonodispersity of the synthesized nanoparticles [51].
FTIR spectra of both synthesized and commercial HAp at different times of immersion in SBF are illustrated
inﬁgure 4. Results suggest that the powder obtained after immersion in SBF is calcium-deﬁcient carbonated
HAp, regardless of the immersion time. Beyond apatite characteristic absorption bands (already described in
detail above) [40], all the spectra exhibit carbonate CO ,32( )- particularly the commercial HAp spectra, and/or
hydrogen phosphate HPO42( )- ions bands. Once formed in SBF, the newCaPphase grows spontaneously
consuming the calcium and phosphate ions andmay incorporateminor ions such as carbonate from ambient
carbon dioxide solubilization [8]. In addition, broadening of the bands, especially phosphate bands (more
pronounced in the commercial HAp spectra) and presence of water peaks indicate low crystallinity.
Figure 5 shows theXRDpatterns of both synthesized and commercial HAp powders after 0, 15 and 60 days
of soaking in SBF solution at 37 °C.Results obtained show the formation of low crystalline carbonatedHAp for
both powders immersed in SBF, once all the patterns exhibit all themajor peaks of apatite phase and fewminor
peaks corresponding to carbonatedHAp.One can also verify that peak broadening ismoremarked in the
synthesizedHAp, suggesting low crystallinity and small crystal size.
The results obtained suggest thus that both synthesized and commercial HAp powders support the
precipitation of small size and low crystalline carbonated and/or calcium-deﬁcientHAp on their surface,
characteristics similar to the apatite phase present in natural bone [11, 27, 39]. It is important to underline that
unlike the commercial HAp, the synthesizedHApwas collected as-preparedwithout further treatment such as
ripening (ageing) process and dried at a low temperature.
In vitro cytotoxicity and cell behavior
Saos-2 cells, a widely used permanent line of human osteoblastic-like cells [52], were cultured in direct contact
with different concentrations of both synthesized and commercial HAp particles for 1, 3 and 7 days. The
eventual cytotoxic events and biological behavior were assessed throughMTS andDNAquantiﬁcation and SEM
qualitative analysis.MTS analysis showed that no cytotoxic events were registered (ﬁgure 6(A)). In fact, a
signiﬁcant increase in cell activity was observed over the culture period for all tested conditions (p< 0.05,
p< 0.01, p< 0.001). In this study, no signiﬁcant differences were obtained between the developedHAp
nanoparticles and the commercial HAp, except at the concentrations of 30 and 50 μg ml−1, where cell activity
was signiﬁcantly higher (p< 0.05) for cells cultured on the developedHApnanoparticles. DNAquantiﬁcation
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results (ﬁgure 6(B)) showed that after 24 h of exposure at varying concentrations of synthesized and commercial
HAp particles, no signiﬁcant differences were observed between all the tested conditions. After 3 days of culture
a notorious increase in cell proliferationwas observed onC1 condition, at signiﬁcant levels (p< 0.05) as
compared toC3 condition. No signiﬁcant differences were obtained between the remaining tested systems and
the proliferation ratewas not signiﬁcantly different between day 1 and day 3 of culture. After 7 days of culture,
the proliferation ratewas signiﬁcantly higher onC1 (p< 0.01) andC2 (p< 0.001) conditions, in comparison to
the highest concentration of the preparedHApnanoparticles (C4).Moreover, theDNA content was signiﬁcantly
higher (p< 0.01) for cells cultured on the synthesizedHApnanoparticles at the concentrations of 30 and
50 μg ml−1, as compared to the commercial HAp. TheDNA valueswere also signiﬁcantly higher (p< 0.05,
p< 0.01, p< 0.001) for the preparedHAp conditions (except for C4) on day 7, compared to the early culture
periods. These results are consistent with those reported byDepan et al [41]where pre-osteoblastic cells cultured
for 7 days in the presence of aHAp-chitosan (CS)–graphene oxide (GO) system showed an increase ofmetabolic
activity, as compared to the pure non-biomineralized system. Chen et al [42] also observed thatMC3T3-E1 cells
viability increased over 7 days of culture in the presence of increasing concentrations (0–1 mgml−1) of
unchargedHApnanoparticles. The same cell behavior was observed for cells cultured on differently charged
HApnanoparticles with dosage of 1 mg ml−1. In another study, Cai et al [4] observed an increase of bone
Figure 6.Cell viability and proliferationmeasured by (A)MTS test and (B)DNAquantiﬁcation, respectively, for Saos-2 cells cultured
in direct contact with synthesized and commercial HAp particles, for 1, 3 and 7 days of culture. Data were analysed asmean±
standard deviationwith n= 9 for each bar. Statistical analysis was performedwithGraphPad Prism5.0 (GraphPad Software) using the
Kruskal-Wallis test followed byDunn’smethod asMultiple Comparision post-test. The signiﬁcance level was *p< 0.05, **p< 0.01,
***p< 0.001.
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marrowmesenchymal stem cells (MSCs) and osteosarcoma cells (U2OSs) proliferation after 7 days of culture on
HApnanoparticles with different average diameters. On the other side, Shi et al [53] veriﬁed thatHApparticles
size inﬂuences greatly the proliferation of human osteoblast-likeMG-63 cells, nanosizedHAphaving the best
effect on the proliferation rate when compared tomicrosziedHAp. This is in agreement with the results
obtained, as best proliferation rates were observed for cell cultured on the preparedHApparticles. Indeed,
synthesizedHApwas proven to be nanosized (see ﬁgures 2 and 3) and has a higher speciﬁc surface area (see
table 2)when compared to the commercial HAp, which promotes cell attachment and therebymay explain the
higher proliferation rate and activity observed. Therefore, it is suggested that the synthesizedHApnanoparticles
can exhibit a favorable inﬂuence over cell proliferation rate and activity, inwhich the size and concentration rate
are believed to play a key role.
The analysis of SEM results (ﬁgure 7) conﬁrmed cell-material interactions over the culture period for all the
tested concentrations, once cells were able to attach and spread on both types ofHApparticles exhibiting aﬂat
appearance. After 1 day of cell culture, the cell spreading can be viewed as exhibiting a ﬂat appearance for all the
tested conditions (ﬁgure 7(A)). After 3 days of culture, a notorious proliferationwas observed on the synthesized
HAp–30 μg ml−1 system (ﬁgure 7(B)), which is consistent with the results obtained byDNAquantiﬁcation
analysis. However nomajor differences were observed between the remaining tested conditions. HAp particles
have gained a particular reputation as bone substitutematerials. Depending on the particle size, theHApmay
play a different role in the regeneration of bone-defect areas. It has been reported thatHApparticles can facilitate
bone remodeling induced by osteoclasts and osteoblasts [54]. Balasundaram and colleagues [55] also studied
nanosized and low crystalline calciumphosphate basedmaterials. They reported that small size and low
crystallineHApmay promote osteoblast adhesion to the same degree as thewell-established techniques of
functionalizing conventionalHApwith RGD. Beyond the alreadymentioned advantages of nanosizedHAp in
promoting a higher surface area for cell adherence, surface chemistry and topography of lower crystallinity is
Figure 7. SEMmicrographs illustrating themorphology, distribution and proliferation of Saos-2 cells cultured in direct contact with
synthesized and commercial HAp particles, for (A) 1 day; (B) 3 days (C) and 7 days of culture.
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favorable for cell attachment [56]. Namely, the existence of a hydrated surface layer on the producedHAp
increases the number of adsorption sites [49]. Concerning cellmorphology, Depan et al [41] observed that after 1
day of pre-osteoblasts seeding in the presence of aHAp-CS–GO system, the cell spreading can be viewed as
exhibiting a predominantly ﬂat appearancewith signiﬁcant cytoplasm, whichwas also veriﬁed in this work. In
their turn, Shi et al [53] investigated the inﬂuence ofHApnanoparticles size inMG-63 cell linemorphology after
5 days of culture.MG-63 cells presented a polygonal formwithﬁne ﬁlopodia and abundant surface folds on
particles with diameters of 20 nm,while spherical or round cells with fewer ﬁlopodiawere observed on particles
with diameters of 80 nm, presenting somemorphological changes, such as swollenmitochondria, deformed
nucleus and condensed chromatin. In addition, ﬁgure 7(C) clearly demonstrates that Saos-2-cultured for 1week
actively involved and phagocytized theHApparticles, while extendingmany projections. By contrast,
Hatakeyama et al [3] reported that Saos-2 cells actively phagocytized nanosizedHAp/Col composites only after
4weeks of culture, appearing as spheroids with cytoplasmic projections. As shown inﬁgure 7(C), cells
preferentially covered and spread over the aggregatedHApparticles after 1week of culture. In a different study,
Chen et al [42] revealed by transmission electronmicroscopy (TEM) analysis thatMC3T3-E1 cell line was able to
encapsulate different chargedHApnanoparticles after 3 days of culture with similar size and shape (100 nm in
length, 20 nm in diameter) as the preparedHAp.
The results presented above are thereby very encouraging regarding biomedical applications, since besides
in vitro apatite-forming activity, the synthesizedHApnanoparticles stimulated cell proliferation.Moreover, the
designed processing conditions can allow for the precise control of the nanoparticles size, in a continuousmode
production. This aspect is very important thus allowing for the scaling up and further industrialization of the
systemwithout compromising physico-chemical properties of the obtainedHAp and eliminating batch to batch
variability.
Conclusions
In the present work,HApnanoparticles previously produced by awet chemical precipitation in a scaled-up
meso oscillatoryﬂow reactor (meso-OFR) operating in continuousmode and a commercial HAp, assessed as a
control condition, were tested to evaluate their biological activity and effects over cell viability and proliferation.
Physico-chemical characterization show that both synthesized and commercial HAp are calcium-deﬁcient
carbonatedHAp, although calcium content of the synthesizedHAp is lower. In addition, results conﬁrm the
smaller size and higher speciﬁc surface area of the synthesizedHApwhen compared to the commercial HAp.
Furthermore, in vitromineralization studies evidenced the formation of a bone-like apatite on the surface of
bothHAppowders, in the presence of SBF, revealing that both types of particles have in vitro apatite-forming
activity. Different concentrations of both synthesized and commercial HAp particles were used to evaluate the
in vitro biological behavior of human Saos-2 osteoblast-like cells. All the testedHAppowders induced a positive
inﬂuence over cell activity and proliferation.Nevertheless, synthesizedHApnanoparticles applied at lower
concentrations have the greatest potential over cell behavior, although their internalization by cells was
observed. Furthermore, in vitromineralization studies evidenced the higher surface reactivity of the synthesized
HApover the commercial.
The present workmay provide improved understanding of the functional properties of nanobiomaterials
and the potential applications ofHApnanoparticles frombiomedicalmaterials to delivery vehicles and
bioimaging. The results are also very promising regarding the designedHAppreparationmethodology, asHAp
nanoparticles with controlled physico-chemical properties were synthesized in a continuousmode, allowing
thus further scaling up of the systemwithout compromising properties of the resultingHAp.
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